EW stock: buy or sell?
May 22nd, 2020
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally.
Should I buy EW stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to define your own trading plan that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Edwards Lifesciences stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Edwards Lifesciences stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.Unfortunately, we couldn't find any rating for EW stock for the last month.
EW stock analysis
Shares of Edwards Lifesciences remained stable a tight 0.14% and closed at $218.81.
Edwards Lifesciences closed on Friday at $218.81 and remained stable a tight 0.14%. In the last 13 days when EW stock price broke down the SMA200d line, it slid $-6.24 per share (-2.77%).
Shares of Edwards Lifesciences jumped a decent 2.75% this week. Late April EW collapsed a hair-raising -6.76% in just one week. By mid April EW boosted a super good 5.68% in just one week.
Edwards Lifesciences stock just marked a top under its last top. Athought it's not concerning right now, investors should be on alert as this could be a warning for future complications. Sliding under its previous bottom at would confirm the downtrend path. Since late April, when EW stock price broke down the 40-weeks moving avarage line, it slid $-4.67 per share (-2.09%). Stocks under the 200 days moving average line are usually not recommended for average traders. Far behind is the all-time high Edwards Lifesciences recorded by mid November 2019 and since then the price is -11.64% below that top.
EW stock price history
EW stock went public on March 27th, 2000 with a price of $3.811. Since then, EW stock grew a 5,643.00%, with a yearly average of 282.20%. If you had invested $1,000 in EW stock in 2000, it would worth $56,430.00 today.
1: Adjusted price after possible price splits or reverse-splits.
EW stock historical price chart
EW stock reached all-time highs on November with a price of $247.64.
EW stock price targetHow much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not detected any price target for Edwards Lifesciences stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report , Edwards Lifesciences . As soon as we get its actual EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Edwards Lifesciences annual sales escalated a remarkable 8.37% to $3,722.80 million USD from $3,435.30 marked in 2017. By contrast, its income margin (compared to sales) raised to 19.40%, that is $722.20 million. Edwards Lifesciences fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Edwards Lifesciences TTM sales up to March 2019 were $3,821.00 and income $765.30 million USD. When comparing this TTM figures with the last reported annuality, we can esteem Edwards Lifesciences business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, grew a slightly good 2.64%. Regarding profit margin, Edwards Lifesciences stayed stable 0.63% to 19.40%
|2013||$2,050 M||-||$392 M19.1%||-|
|2014||$2,323 M||13.31%||$811 M34.9%||107.07%|
|2015||$2,494 M||7.35%||$495 M19.8%||-38.98%|
|2016||$2,964 M||18.85%||$570 M19.2%||15.07%|
|2017||$3,435 M||15.91%||$584 M17.0%||2.48%|
|2018||$3,723 M||8.37%||$722 M19.4%||23.75%|
|TTM||$3,821 M||2.64%||$765 M20.0%||5.97%|
Quarterly financial resultsEdwards Lifesciences posted $993.00 M in sales for 2019-Q1, a 1.56% up compared to previous quarter. Reported quarter income marked $249.70 M with a profit margin of 25.15%. Profit margin skyrocketed a 24.43% compared to previous quarter when profit margin was 0.72%. When comparing sales to same quarter last year, Edwards Lifesciences sales marked an impressive gain and rocketed a 10.97%. Looking back to recent quarterly results, Edwards Lifesciences posted 2 negative quarters in a row.
|2017-Q2||$842 M||-||$186 M22.1%||-|
|2017-Q3||$822 M||-2.41%||$170 M20.7%||-8.60%|
|2017-Q4||$889 M||8.16%||$-3 M-0.3%||-101.65%|
|2018-Q1||$895 M||0.71%||$207 M23.1%||-7,478.57%|
|2018-Q2||$944 M||5.46%||$283 M30.0%||36.83%|
|2018-Q3||$907 M||-3.93%||$226 M24.9%||-20.09%|
|2018-Q4||$978 M||7.84%||$7 M0.7%||-96.90%|
|2019-Q1||$993 M||1.56%||$250 M25.1%||3,467.14%|
Edwards Lifesciences ownershipWhen you are planning to invest in shares of a company, it's worth to check its ownership structure.
Edwards Lifesciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.67% of all shares.
Bearish positions for EW stock account 0.00%, no big difference from last month.
For a better understanding, the next table shows ownership data compared to other related stocks:
|Market cap||$46.4 B|
|Total shares||212.0 M|
|Float shares||205.0 M|
|- Institutional holdings (%)||89.1%|
|- Insider holdings (%)||0.7%|
|Shares in short selling||0.0%|
|Friday, May 22nd, 2020|
|Day range||$215.05 - $219.05|
|Average true range||$6.72|
|50d mov avg||$204.69|
|100d mov avg||$215.18|
|200d mov avg||$221.85|
Edwards Lifesciences performanceTo better understand Edwards Lifesciences performance you must becnhmark its gains with other related stocks in same sector or industry. In the following table, we compare Edwards Lifesciences performance to :
Edwards Lifesciences competitorsUnfortunately, we could not find any public company that could be defined as Edwards Lifesciences competitor. This doesn't mean Edwards Lifesciences does not have any competitor in the market, it's just we could not detected it.
Latest EW stock news
- Seeking AlphaEdwards Lifesciences Beats, Raises And Surges: AnalysisJuly 24, 2019
- Seeking AlphaEdwards Lifesciences: A Med-Tech Stock Staying Strong For A ReasonMay 15, 2019
- Seeking AlphaEdwards Lifesciences: Assessing The Next MovesMay 1, 2019
- Seeking AlphaEdwards Lifesciences: It's Expensive, But It's Recession-ProofFebruary 20, 2019
- Seeking AlphaEdwards Lifesciences: Good For The Heart And Your PortfolioAugust 17, 2018